Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Trial Refresh: A Case for an Adaptive Platform Trial for Pulmonary Exacerbations of Cystic Fibrosis.

Schultz A, Marsh JA, Saville BR, Norman R, Middleton PG, Greville HW, Bellgard MI, Berry SM, Snelling T.

Front Pharmacol. 2019 Mar 28;10:301. doi: 10.3389/fphar.2019.00301. eCollection 2019. Review.

2.

Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial.

Serisier DJ, Bilton D, De Soyza A, Thompson PJ, Kolbe J, Greville HW, Cipolla D, Bruinenberg P, Gonda I; ORBIT-2 investigators.

Thorax. 2013 Sep;68(9):812-7. doi: 10.1136/thoraxjnl-2013-203207. Epub 2013 May 16.

3.

Determinants of adherence in adults with cystic fibrosis.

Kettler LJ, Sawyer SM, Winefield HR, Greville HW.

Thorax. 2002 May;57(5):459-64. Review.

4.

Arterial hypoxaemia in endurance athletes is greater during running than cycling.

Rice AJ, Scroop GC, Thornton AT, McNaughton NS, Rogers KJ, Chapman MJ, Greville HW, Scicchitano R, Gore CJ.

Respir Physiol. 2000 Nov;123(3):235-46.

PMID:
11007990
5.

Pulmonary gas exchange during exercise in highly trained cyclists with arterial hypoxemia.

Rice AJ, Thornton AT, Gore CJ, Scroop GC, Greville HW, Wagner H, Wagner PD, Hopkins SR.

J Appl Physiol (1985). 1999 Nov;87(5):1802-12.

6.

Exercise-induced hypoxaemia in highly trained cyclists at 40% peak oxygen uptake.

Rice AJ, Scroop GC, Gore CJ, Thornton AT, Chapman MA, Greville HW, Holmes MD, Scicchitano R.

Eur J Appl Physiol Occup Physiol. 1999 Mar;79(4):353-9.

PMID:
10090636
7.

Pulmonary disease from exposure to an artificial aluminium silicate: further observations.

Musk AW, Beck BD, Greville HW, Brain JD, Bohannon DE.

Br J Ind Med. 1988 Apr;45(4):246-50.

8.

Density dependence of maximal flow is lung volume dependent during bronchoconstriction.

Greville HW, Arnup ME, Mink SN.

J Appl Physiol (1985). 1987 Feb;62(2):691-705.

PMID:
3558229
9.

Mechanism of reduced maximum expiratory flow in dogs with compensatory lung growth.

Greville HW, Arnup ME, Mink SN, Oppenheimer L, Anthonisen NR.

J Appl Physiol (1985). 1986 Feb;60(2):441-8.

PMID:
3949649
10.

Irreversible airflow obstruction. Evolution in asthma.

Finucane KE, Greville HW, Brown PJ.

Med J Aust. 1985 May 27;142(11):602-4.

PMID:
4000023
11.

Dynamic lung function in dogs with compensatory lung growth.

Arnup ME, Greville HW, Oppenheimer L, Mink SN, Anthonisen NR.

J Appl Physiol Respir Environ Exerc Physiol. 1984 Nov;57(5):1569-76.

PMID:
6520054
12.

Asthma and irreversible airflow obstruction.

Brown PJ, Greville HW, Finucane KE.

Thorax. 1984 Feb;39(2):131-6.

13.

Effect of previous volume history on airway closure.

Greville HW, Slykerman LJ, Easton PA, Anthonisen NR.

J Appl Physiol Respir Environ Exerc Physiol. 1983 Aug;55(2):294-9.

PMID:
6618922
14.

Supplemental Content

Loading ...
Support Center